|
|
|
|
|
|
|
|
|
|
|
|
|
Your Source for Separation Solutions
|
|
|
|
|
Q1 2020 Recap
Greetings!
Q1 2020 has come to a close and while almost everyone is finding themselves negatively affected by the coronavirus outbreak, we at YMC America are keeping a positive attitude and looking forward to a return to normalcy, not just for us, but for every one of our customers as well.
See below for a quick list of our latest updates and developments:
WE ARE STILL SERVING OUR CUSTOMERS
YMC America has been fortunate enough to remain open and operational due to the critical role many of our customers play in supporting not just normal everyday life, but particularly in the fight against COVID-19. In light of the most recent government briefings, we have adapted our working practices in line with their recommendations to include social distancing and modified work patterns, including working remotely for employees whose jobs allow it. Although we have taken these precautions, we remain committed to responding to our customers' needs and do not foresee a slowdown in the shipment of our products or in our customer support response times.
|
|
|
WHITEPAPER ALERT
In conjunction with Chemical & Engineering News, we published a new whitepaper on the fundamentals for analysis and purification of biologics. You can download your copy here:
Whitepaper Download
|
|
|
|
|
|
|
NEW APP NOTE: CANNABINOIDS
Our latest contribution to the ever-expanding cannabis industry comes in the form of a new application note developed at a customer's request. It serves as a proof-of-concept for analyzing cannabidiol and melatonin in an over-the-counter (OTC) sleep aid:
App Note Download
|
|
|
|
|
|
|
NEW COLUMN: YMC BIOPRO HIC HT
During the Pittcon Conference and Expo in early March, YMC released it's latest product for biomolecules:
BioPro HIC HT
Designed for high resolution, high-throughput "HT" analysis, this novel 2.3µm HIC stationary phase excels at drug-to-antibody ratio (DAR) analysis of antibody drug conjugates (ADCs), as well as other protein and mAb separations.
More Info
|
|
|
|
|
|
|
|
|
YMC CHIRAL ART Cellulose-SJ
An extremely versatile polysaccharide-based chiral phase utilizing a cellulose-tris(4-methylbenzoate) selector. It's immobilized nature allows for a wider usable solvent range than coated phases. Available in a variety of particle sizes and column geometries.
|
|
YMC-Triart
Bio C18
Another relatively new biomolecule product (released late 2019), Triart Bio C18 is a 300Å C18 phase designed specifically for proteins, peptides, and oligonucleotides. As with all products in the Triart family, Bio C18 offers wide temperature and pH ranges for versatile method development.
|
|
|
|
|
|
YMC America, Inc.
941 Marcon Boulevard, Suite 201, Allentown, PA 18109
|
|
|
|
|
|
|
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of LCGC, an MJH Life Sciences™ brand. You are on the mailing list as %%emailaddress%%.
|
|
